Wave Life Sciences
92 hedge funds and large institutions have $1.19B invested in Wave Life Sciences in 2018 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 25 increasing their positions, 27 reducing their positions, and 9 closing their positions.
156% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 9
27% more capital invested
Capital invested by funds: $936M → $1.19B (+$254M)
18% more funds holding
Funds holding: 78 → 92 (+14)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
7% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 27
2.86% less ownership
Funds ownership: 84.04% → 81.18% (-2.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$11.1M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$7.96M |
| 3 |
Millennium Management
New York
|
+$3.9M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.26M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.45M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$16.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$12.6M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$7.04M |
| 4 |
DM
Deerfield Management
New York
|
-$6.84M |
| 5 |
BM
Bridger Management
New York
|
-$6.62M |
WVE Hedge Fund Activity: Q3 2018 in Review
92 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q3 2018, worth a combined $1.19B — up 27% from $936M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new WVE positions and 9 closed out — a net gain of 14 holders — while 25 added to existing stakes and 27 trimmed.
The largest buyer was BB Biotech, adding an estimated $11.1M. The largest seller was EcoR1 Capital, cutting an estimated $16.6M.
- 92 institutional investors held Wave Life Sciences (WVE) as of Q3 2018, up from 78 in Q2 2018.
- Funds reported $1.19B of Wave Life Sciences stock for Q3 2018, up 27% quarter-over-quarter.
- 23 funds opened new Wave Life Sciences positions in Q3 2018 and 9 closed out, a net change of +14 holders.
- The largest Wave Life Sciences buyer in Q3 2018 was BB Biotech, an estimated $11.1M added.
- The largest Wave Life Sciences seller in Q3 2018 was EcoR1 Capital, an estimated $16.6M sold.
Based on aggregated 13F filings for Q3 2018.